Vikas Sinha

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cheshire, CT
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Junlin Ho, Attorney-in-Fact for Vikas Sinha
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Vikas Sinha

Form 4 holding Officer Title: President, Chief Financial Officer and Chief Executive Officer, Director, 10%+ Owner

Allovir, Inc.

Security class
Common Stock
Shares / value
724,989
Estimated value
$7,304,844
Report date
21 Feb 2025
Price
$10.08
Ownership
Indirect
Form 4 holding Officer Title: President, Chief Financial Officer and Chief Executive Officer, Director, 10%+ Owner

Allovir, Inc.

Security class
Common Stock
Shares / value
49,129
Estimated value
$495,014
Report date
21 Feb 2025
Price
$10.08
Ownership
Direct
Form 4 holding Chief Financial Officer

Scholar Rock Holding Corp

Security class
Stock Option (Right to Buy)
Shares / value
110,067
Estimated value
Report date
02 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Verona Pharma plc

Security class
Restricted Share Units
Shares / value
96,000
Estimated value
Report date
25 Apr 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

Verona Pharma plc

Security class
Restricted Stock Units
Shares / value
72,000
Estimated value
Report date
01 Aug 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

Verona Pharma plc

Security class
Share Options (Right to Buy)
Shares / value
0
Estimated value
Report date
07 Oct 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Vikas Sinha

4 KLRS

Allovir, Inc.

Report period
21 Feb 2025
Transactions
1
Transaction value
-$3,053
Accepted by SEC
24 Feb 2025, 16:15
Role
Officer Title: President, Chief Financial Officer and Chief Executive Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
23 Jan 2025
Transactions
2
Transaction value
-$1,226
Accepted by SEC
27 Jan 2025, 16:11
Role
Officer Title: President, Chief Financial Officer and Chief Executive Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
10 Jan 2025
Transactions
1
Transaction value
-$431
Accepted by SEC
13 Jan 2025, 16:15
Role
Officer Title: President, Chief Financial Officer and Chief Executive Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
19 Nov 2024
Transactions
1
Transaction value
-$1,748
Accepted by SEC
20 Nov 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
05 Nov 2024
Transactions
1
Transaction value
-$4,442
Accepted by SEC
06 Nov 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
21 Oct 2024
Transactions
2
Transaction value
-$2,649
Accepted by SEC
23 Oct 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
03 Oct 2024
Transactions
1
Transaction value
-$766
Accepted by SEC
04 Oct 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
19 Aug 2024
Transactions
1
Transaction value
-$2,399
Accepted by SEC
20 Aug 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
05 Aug 2024
Transactions
1
Transaction value
-$3,858
Accepted by SEC
07 Aug 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
19 Jul 2024
Transactions
2
Transaction value
-$2,530
Accepted by SEC
23 Jul 2024, 16:27
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
02 Jul 2024
Transactions
1
Transaction value
-$676
Accepted by SEC
03 Jul 2024, 16:14
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
17 May 2024
Transactions
1
Transaction value
-$2,355
Accepted by SEC
21 May 2024, 16:33
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
03 May 2024
Transactions
1
Transaction value
-$3,946
Accepted by SEC
07 May 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
19 Apr 2024
Transactions
2
Transaction value
-$2,534
Accepted by SEC
23 Apr 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
02 Apr 2024
Transactions
1
Transaction value
-$683
Accepted by SEC
04 Apr 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
20 Feb 2024
Transactions
1
Transaction value
-$2,011
Accepted by SEC
22 Feb 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
05 Feb 2024
Transactions
1
Transaction value
-$12,282
Accepted by SEC
06 Feb 2024, 16:46
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
23 Jan 2024
Transactions
1
Transaction value
-$2,150
Accepted by SEC
25 Jan 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
04 Jan 2024
Transactions
1
Transaction value
-$614
Accepted by SEC
08 Jan 2024, 16:15
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
17 Nov 2023
Transactions
1
Transaction value
-$4,061
Accepted by SEC
21 Nov 2023, 17:00
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
19 Oct 2023
Transactions
2
Transaction value
-$4,220
Accepted by SEC
23 Oct 2023, 17:00
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
03 Oct 2023
Transactions
1
Transaction value
-$1,492
Accepted by SEC
05 Oct 2023, 17:00
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
17 Aug 2023
Transactions
1
Transaction value
-$26,243
Accepted by SEC
21 Aug 2023, 17:00
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
19 Jul 2023
Transactions
2
Transaction value
-$9,077
Accepted by SEC
21 Jul 2023, 17:00
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
05 Jul 2023
Transactions
1
Transaction value
-$9,084
Accepted by SEC
06 Jul 2023, 17:00
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
19 Apr 2023
Transactions
2
Transaction value
-$9,828
Accepted by SEC
21 Apr 2023, 16:05
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
02 Feb 2023
Transactions
2
Transaction value
$0
Accepted by SEC
03 Feb 2023, 16:00
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
19 Jan 2023
Transactions
2
Transaction value
-$33,287
Accepted by SEC
23 Jan 2023, 18:00
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
19 Oct 2022
Transactions
1
Transaction value
-$13,564
Accepted by SEC
24 Oct 2022, 18:28
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
16 Aug 2022
Transactions
1
Transaction value
$0
Accepted by SEC
17 Aug 2022, 18:04
Role
Officer Title: President and Chief Financial Officer, Director
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
28 Jul 2022
Transactions
1
Transaction value
+$15,000,000
Accepted by SEC
01 Aug 2022, 16:38
Role
Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
20 Jul 2022
Transactions
1
Transaction value
-$7,467
Accepted by SEC
21 Jul 2022, 19:12
Role
Officer Title: President and Chief Financial Officer, Director
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
01 Jul 2022
Transactions
2
Transaction value
$0
Accepted by SEC
06 Jul 2022, 07:30
Role
Officer Title: President and Chief Financial Officer, Director
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
20 Apr 2022
Transactions
1
Transaction value
-$7,767
Accepted by SEC
22 Apr 2022, 08:29
Role
Officer Title: President and Chief Financial Officer, Director
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
20 Jan 2022
Transactions
1
Transaction value
-$56,454
Accepted by SEC
24 Jan 2022, 15:15
Role
Officer Title: President & Chief Financial Officer, Director
Next action
Open filing details
4 KLRS

Allovir, Inc.

Report period
18 Jan 2022
Transactions
2
Transaction value
$0
Accepted by SEC
04 Apr 2022, 16:25
Role
Officer Title: President and Chief Financial OFficer, Director
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .